You searched for "invasive"

401 results found

Manfred Sauer looks forward to seeing you at the BAUN Conference 2022 on STAND 9

We are a manufacturer and supplier of continence care products with a difference. Our products are often designed by patients and healthcare professionals with innovative and unique features and benefits.

Men's Liberty case study reduces catheter days with ZERO CAUTI: Management of Urinary Incontinence in Retracted Penis

Men’s Liberty™ is the innovative alternative to traditional male external catheters.

Action Bladder Cancer UK to open applications for bladder cancer research grants

Action Bladder Cancer UK (ABC UK) will open applications in November 2024 for its 2026 research funding programmes, supporting projects that improve the care, treatment, or diagnosis of bladder cancer. Grants are offered under two schemes. The Improving Outcomes for...

Action Bladder Cancer UK offering grants for bladder cancer research

Action Bladder Cancer UK (ABC UK) is inviting applications for its 2026 research funding programmes, supporting projects that improve the care, treatment or diagnosis of bladder cancer. Grants are offered under two schemes. The Improving Outcomes for Patients Programme (IOPP)...

Action Bladder Cancer UK offers nursing grants for projects supporting bladder cancer

Action Bladder Cancer UK (ABC UK) is inviting specialist urology and cancer nurses to apply for funding to deliver nurse-led projects that improve bladder cancer care, patient experience and treatment pathways. The ABC UK Nursing Grants Programme offers grants of...

New techniques in UTI diagnosis

Urinary tract infection (UTI) is a common reason for seeking medical care in both primary and secondary settings. Half of women will have at least one episode of cystitis in their lifetime, and a third of them will have experienced...

Clitoral reconstructive surgery after female genital cutting

Practised in Africa and other parts of the world, the WHO recently estimated that over 250 million females have been circumcised so far, and an additional three million are at risk of circumcision each year...

PSA screening in limbo: how low should we go?

One may wonder how the management of prostate cancer could have evolved differently if it had followed a path similar to breast cancer. In breast cancer, early detection in the 1970s relied heavily on imaging because no reliable circulating biomarker...

Mo Belal: a journey of perseverance, resilience and representation

In this interview, we have the privilege of speaking with Mr Mo Belal, a leading consultant urologist whose career and life took an extraordinary turn following a spinal injury. Renowned for his expertise and dedication to patient care, Mr Belal...

Mesh in urological surgery in the UK – background, reviews and current status

All UK urologists, unless they have been on a 10-year silent retreat, are by now aware of the controversy surrounding surgical use of mesh in general and urological / urogynaecological use of mesh for the surgical treatment of stress urinary...

A guide to percutaneous nephrolithotomy

Percutaneous nephrolithotomy (PCNL) is now the gold standard approach to treating large renal stones. Since its development in the 1970s, it has undergone a series of refinements that could only have been possible with the symbiosis of both radiological and...

Sexual dysfunction following prostate cancer treatment

Prostate cancer is common with over 52,300 new cases diagnosed annually in the UK; this is expected to rise by 15% between 2023-2025 and 2038-2040 [1]. Radical prostatectomy continues to be the most common form of radical treatment for men...